Susan Wiviott
Algemeen Directeur bij The Bridge /NY/
Profiel
Susan Wiviott is currently the Chief Executive Officer at The Bridge and a Director at Kadmon Corp.
LLC.
She is also a Member of The District of Columbia Bar.
Previously, she worked as an Independent Director at Kadmon Holdings, Inc. from 2010 to 2019.
She was also an Executive Vice President at Jewish Board of Family & Children's Services, Inc. from 1999 to 2012 and the Chief Program Officer at Palladia, Inc. from 2012 to 2014.
Additionally, she worked as an Associate Commissioner-Planning Development at New York City Department of Homeless Services.
She started her career as an Associate at Sidley & Austin and later worked as a Project Director at New York State Commission on Public Integrity.
Ms. Wiviott received her undergraduate degree from the University of Wisconsin and her graduate degree from Harvard Law School.
Actieve functies van Susan Wiviott
| Bedrijven | Functie | Begin |
|---|---|---|
Kadmon Corp. LLC
 Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | Directeur/Bestuurslid | - |
The District of Columbia Bar
 The District of Columbia Bar Miscellaneous Commercial ServicesCommercial Services The District of Columbia Bar provides legal services. The private company is based in Washington. | Corporate Officer/Principal | - |
| The Bridge /NY/ | Algemeen Directeur | 01-01-2014 |
Eerdere bekende functies van Susan Wiviott
| Bedrijven | Functie | Einde |
|---|---|---|
| KADMON HOLDINGS, INC. | Directeur/Bestuurslid | 15-05-2019 |
Palladia, Inc.
 Palladia, Inc. Personnel ServicesCommercial Services Palladia, Inc. used to provide healthcare services. The company offered homeless, substance, alcohol addiction Treatment, domestic violence and behavioral heath services. Palladia was founded in 1970 and was headquartered in New York, NY. | Corporate Officer/Principal | 01-01-2014 |
Jewish Board of Family & Children's Services, Inc.
 Jewish Board of Family & Children's Services, Inc. Services to the Health IndustryHealth Services Jewish Board of Family & Children's Services, Inc. is a non-profit company that provides website hosting services. The company is based in New York, NY. The company has over 25 years of experience and offer a variety of web hosting plans with 99.9% server uptime. The company's services are supported by 24/7 technical support from real employees. | Corporate Officer/Principal | 01-01-2012 |
| Sidley & Austin | Corporate Officer/Principal | - |
| New York State Commission on Public Integrity | Corporate Officer/Principal | - |
Opleiding van Susan Wiviott
| University of Wisconsin | Undergraduate Degree |
| Harvard Law School | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Kadmon Holdings, Inc.
 Kadmon Holdings, Inc. BiotechnologyHealth Technology Kadmon Holdings, Inc. is a biopharmaceutical company, which engages in discovering, developing, and commercializing small molecules and biologics to address unmet medical need. The company's clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies. The firms late-stage product candidate KD025, which is an orally administered selective inhibitor of Rho-associated coiled-coil kinase engages in development for the treatment of inflammatory and fibrotic diseases. The firm's a pivotal clinical trial of KD025 is underway in chronic graft-versus-host disease (cGVHD), as well as a Phase 2 clinical trial in systemic sclerosis. It is also developing next-generation immuno-oncology therapies, specifically IL-15 containing fusion proteins, for the treatment of cancer. The company's lead I-O product candidate, KD033, is an anti-PD-L1/IL-15 fusion protein. Kadmon was founded by Steven N. Gordon in September 2010 and is headquartered in New York, NY. | Health Technology |
| Sidley & Austin | Commercial Services |
The District of Columbia Bar
The District of Columbia Bar Miscellaneous Commercial ServicesCommercial Services The District of Columbia Bar provides legal services. The private company is based in Washington. | Commercial Services |
Jewish Board of Family & Children's Services, Inc.
Jewish Board of Family & Children's Services, Inc. Services to the Health IndustryHealth Services Jewish Board of Family & Children's Services, Inc. is a non-profit company that provides website hosting services. The company is based in New York, NY. The company has over 25 years of experience and offer a variety of web hosting plans with 99.9% server uptime. The company's services are supported by 24/7 technical support from real employees. | Health Services |
| New York State Commission on Public Integrity | Government |
Palladia, Inc.
Palladia, Inc. Personnel ServicesCommercial Services Palladia, Inc. used to provide healthcare services. The company offered homeless, substance, alcohol addiction Treatment, domestic violence and behavioral heath services. Palladia was founded in 1970 and was headquartered in New York, NY. | Commercial Services |
| New York City Department of Homeless Services | Government |
Kadmon Corp. LLC
Kadmon Corp. LLC Pharmaceuticals: MajorHealth Technology Kadmon Corp. LLC manufactures and distributes pharmaceutical products. It currently offers products and services for the treatment and management of hepatitis C, is pioneering medicines in oncology, infectious diseases, and immunology and neurodegenerative diseases by using new understandings in molecular biology to develop therapies that target the metabolomic and signaling pathways associated with disease. The company was founded in 2009 and is headquartered in New York, NY. | Health Technology |
| The Bridge /NY/ |